Vanicoside B targets cyclin-dependent kinase 8 (CDK8) and exhibits anti-tumor activity. The potential mechanism is Vanicoside B blocks CDK8-mediated signaling pathways and decreases the expression of epithelial-mesenchymal transition proteins, so that it leads to cell cycle arrest and apoptosis.
Molecular Weight:
956.89
Purity:
>98.0%
CAS Number:
[155179-21-8]
Formula:
C49H48O20
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted
